10-Q Filing

BIO-PATH HOLDINGS, INC. CIK: 1133818 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001144204-17-041665`
Period End Date	20170630
Filing Date	20170809
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	bpth-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 56 Cash Flow Statement 50

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred Stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash	`Cash`	$8.85M	USD	Point-in-time
Cash	`Cash`	$6.18M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$9.38M	USD	Point-in-time
Preferred Stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash	`Cash`	$4.22M	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$376.00K	USD	Point-in-time
Preferred Stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Prepaid drug product for testing	`PrepaidExpenseCurrent`	$592.00K	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$1.01M	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$902.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.65M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$7.79M	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	95.64M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	100.06M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	95.64M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	100.06M	shares	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$708.00K	USD	Point-in-time
Furniture, fixtures & equipment	`PropertyPlantAndEquipmentGross`	$999.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$202.00K	USD	Point-in-time
Less accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$94.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$614.00K	USD	Point-in-time
Property, Plant and Equipment, Net	`PropertyPlantAndEquipmentNet`	$797.00K	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Technology licenses	`FiniteLivedLicenseAgreementsGross`	$2.50M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.65M	USD	Point-in-time
Less accumulated amortization	`FiniteLivedIntangibleAssetsAccumulatedAmortization`	$1.57M	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$929.00K	USD	Point-in-time
Intangible Assets, Net (Excluding Goodwill), Total	`IntangibleAssetsNetExcludingGoodwill`	$849.00K	USD	Point-in-time
Total Assets	`Assets`	$12.20M	USD	Point-in-time
Total Assets	`Assets`	$9.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$96.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$969.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$468.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenueCurrent`	$12.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.05M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$576.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$2.91M	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	-	USD	Point-in-time
Total Liabilities	`Liabilities`	$3.96M	USD	Point-in-time
Total Liabilities	`Liabilities`	$576.00K	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 10,000 shares authorized; no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 100,057 and 95,645 shares issued and outstanding, respectively	`CommonStockValue`	$96.00K	USD	Point-in-time
Common stock, $.001 par value; 200,000 shares authorized; 100,057 and 95,645 shares issued and outstanding, respectively	`CommonStockValue`	$100.00K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$40.28M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$43.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-34.52M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-32.13M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.86M	USD	Point-in-time
Total shareholders' equity	`StockholdersEquity`	$8.24M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$9.43M	USD	Point-in-time
Total Liabilities & Shareholders' Equity	`LiabilitiesAndStockholdersEquity`	$12.20M	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Revenue	`Revenues`	-	USD	2 Qtrs
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	1 Quarter
Revenue	`Revenues`	-	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.51M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.48M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.19M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.21M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$845.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$757.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.61M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.81M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$1.94M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$3.81M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$4.32M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$2.33M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-3.81M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-4.32M	USD	2 Qtrs
Net operating loss	`OperatingIncomeLoss`	$-2.33M	USD	1 Quarter
Net operating loss	`OperatingIncomeLoss`	$-1.94M	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-778.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	2 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$5.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$2.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$4.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$4.00K	USD	2 Qtrs
Total other income	`NonoperatingIncomeExpense`	$340.00K	USD	1 Quarter
Total other income	`NonoperatingIncomeExpense`	$1.94M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.38M	USD	2 Qtrs
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	$1.04M	USD	1 Quarter
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	1 Quarter
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	-	USD	2 Qtrs
Deemed dividend related to warrant conversion	`PreferredStockDividendsAndOtherAdjustments`	$1.04M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.81M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.94M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.42M	USD	2 Qtrs
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.02M	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.04	USD	2 Qtrs
Net loss per share, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	98.59M	shares	1 Quarter
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	97.12M	shares	2 Qtrs
Basic and diluted weighted average number of common shares outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	89.76M	shares	1 Quarter

Cash Flow Statement 50 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.81M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.94M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.99M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.38M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$80.00K	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$80.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$21.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$108.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$507.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$318.00K	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-778.00K	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	2 Qtrs
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Change in fair value of warrant liability	`FairValueAdjustmentOfWarrants`	$-2.37M	USD	2 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	1 Quarter
Loss on extinguishment of warrant liability	`GainsLossesOnExtinguishmentOfDebt`	$-440.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$216.00K	USD	2 Qtrs
Prepaid drug product for testing	`IncreaseDecreaseInPrepaidExpense`	$19.00K	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$1.10M	USD	2 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$109.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-257.00K	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-124.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.20M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-4.63M	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	2 Qtrs
Purchases of furniture, fixtures & equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$538.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-538.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	-	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.55M	USD	2 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$1.55M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	-	USD	2 Qtrs
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-4.63M	USD	2 Qtrs
Net decrease in cash	`CashPeriodIncreaseDecrease`	$-3.19M	USD	2 Qtrs
Cash, beginning of period	`Cash`	$8.85M	USD	Point-in-time
Cash, beginning of period	`Cash`	$6.18M	USD	Point-in-time
Cash, beginning of period	`Cash`	$9.38M	USD	Point-in-time
Cash, beginning of period	`Cash`	$4.22M	USD	Point-in-time
Cash, end of period	`Cash`	$8.85M	USD	Point-in-time
Cash, end of period	`Cash`	$6.18M	USD	Point-in-time
Cash, end of period	`Cash`	$9.38M	USD	Point-in-time
Cash, end of period	`Cash`	$4.22M	USD	Point-in-time
Incremental fair value of warrant liability modification	`IncrementalFairValueOfWarrantLiabilityModification`	$797.00K	USD	2 Qtrs
Incremental fair value of warrant liability modification	`IncrementalFairValueOfWarrantLiabilityModification`	-	USD	2 Qtrs
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	$175.00K	USD	2 Qtrs
Conversion of warrant liability to equity	`DebtConversionOriginalDebtAmount1`	-	USD	2 Qtrs
Offering expenses included in accrued expense	`LiabilitiesAssumed1`	$30.00K	USD	2 Qtrs
Offering expenses included in accrued expense	`LiabilitiesAssumed1`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.